Cited by 99Mitochondrial Function and PathologyAutophagy in Disease and TherapyCardiac Ischemia and Reperfusion

A selective inhibitor of mitofusin 1-βIIPKC association improves heart failure outcome in rats

Open access
Ferreira, Julio C. B., Campos, Juliane C., Qvit, Nir, Qi, Xin, Bozi, Luiz H. M., Bechara, Luiz R. G., Lima, Vanessa M., Queliconi, Bruno B. +4 more·2019·Nature Communications

Abstract

We previously demonstrated that beta II protein kinase C (βIIPKC) activity is elevated in failing hearts and contributes to this pathology. Here we report that βIIPKC accumulates on the mitochondrial outer membrane and phosphorylates mitofusin 1 (Mfn1) at serine 86. Mfn1 phosphorylation results in partial loss of its GTPase activity and in a buildup of fragmented and dysfunctional mitochondria in heart failure. βIIPKC siRNA or a βIIPKC inhibitor mitigates mitochondrial fragmentation and cell death. We confirm that Mfn1-βIIPKC interaction alone is critical in inhibiting mitochondrial function and cardiac myocyte viability using SAMβA, a rationally-designed peptide that selectively antagonizes Mfn1-βIIPKC association. SAMβA treatment protects cultured neonatal and adult cardiac myocytes, but not Mfn1 knockout cells, from stress-induced death. Importantly, SAMβA treatment re-establishes mitochondrial morphology and function and improves cardiac contractility in rats with heart failure, suggesting that SAMβA may be a potential treatment for patients with heart failure.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-018-08276-6

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ferreira, J. C. B., Campos, J. C., Qvit, N., Qi, X., Bozi, L. H. M., Bechara, L. R. G., Lima, V. M., Queliconi, B. B., Disatnik, M.-H., Dourado, P. M. M., Kowaltowski, A. J., & Mochly-Rosen, D.
Affiliations
  • Universidade de São Paulo (BR)
  • Stanford Medicine (US)
Corresponding author
Ferreira, Julio C. B.
Venue
Nature Communications
Published
2019-01-18
Volume
10
Issue
1
Pages
329-329
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2909282279
Cited by
99
References
55
Citations by year
2026: 5 · 2025: 7 · 2024: 15 · 2023: 14 · 2022: 26 · 2021: 12 · 2020: 14 · 2019: 5
FWCI
4.71
Type
journal article
Language
en
Open access
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (10/51906-1, 12/05765-2, 2017/11142-1, 2015/, 15/20783-5, 2017/16540‐5, 2015/228145, 407306/2013-7, 17/16694-2, 2010/51906, 470880/2012-0, 2016/09611-0, 2016/01633-5, Code 001)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (2017/16694-2, 2015/20783-5, (Code 001), 2012/05765-2, 2017/16540-5, 2017/11142-1, 407306/2013-7, 470880/2012-0)
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (2015-4, 470880/2012-0, 2017/11142-1, 2015/22814-5, 407306/2013-7, 2012-0, 2017/16694-2, 2017/16540-5, 2012/05765-2, 2015/20783-5)
  • National Heart, Lung, and Blood Institute (R01HL052141)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Cardiac Ischemia and Reperfusion
Keywords
mitofusin 1, heart failure, mitochondrial fragmentation, peptide inhibitors, mitochondrial morphology, cardiac contractility, cardiomyocyte death
MeSH terms
Animals, Heart Failure, Male, Membrane Proteins, Myocardial Contraction, Myocardial Infarction, Peptides, Phosphorylation, Rats, Wistar, GTP Phosphohydrolases, Mitochondrial Proteins, Myocytes, Cardiac, RNA, Small Interfering, Mitochondrial Membranes, Gene Knockout Techniques, Protein Kinase C beta

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review